This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Schistosomiasis Mansoni or HIV
and you are
between 18 and 45
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of this study is to assess the impact of Schistosoma mansoni infection and its treatment on genital immunology and HIV susceptibility in Ugandan women.

Provided treatments

  • Drug: Praziquantel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02878564. The sponsor of the trial is University of Toronto and it is looking for 34 volunteers for the current phase.
Official trial title:
Effect of Schistosomiasis Mansoni and Its Treatment on HIV Susceptibility and Female Genital Immunology